Ocuphire Pharma

Ocuphire Pharma

United States
Ocuphire Pharma is a clinical-stage biopharmaceutical company focuses on the development and commercialization of therapies to treat patients with a variety of ophthalmic disorders. It is currently focused on providing a novel once-daily eye drop treatment option, Nyxol, to treat multiple front-of-the-eye disorders, including night vision disturbances, glaucoma, pharmacologically-induced mydriasis, and presbyopia. Nyxol eye drops are an investigational 505(b)(2) drug candidate in late-stage clinical development with over a decade of safety and efficacy data from Phase 1 and 2 trials. Part of their strategy is to explore opportunities to acquire additional ophthalmic assets for both the front and the back of the eyes and to seek strategic partners for global commercialization. The company was founded in 2018 and is headquartered in Farmington Hills, Michigan.
Founded date
01/02/2018
# of employees
11-50
Company type
For Profit

General & financials

Estimated revenue
$1M to $10M
# of funders
2
Founders
Alan Meyer, Mina Patel Sooch
Industry group
Biotechnology, Health Care, Science and Engineering

Founding

Top 5 investors
Lincoln Park Capital Fund, Altium Capital, Michigan Angel Fund, District 2 Capital, Blue Water Angels
# of funding runds
5
Last founding
$15.000.000
Total funded
$24.560.713

See more companies

See full list
Droplette

Droplette

Estimated revenue
$1M to $10M
# of employees
11-50
Company type
For Profit
ICAgen

ICAgen

Estimated revenue
$10M to $50M
# of employees
11-50
Company type
For Profit
Rx Savings Solutions

Rx Savings Solutions

Estimated revenue
$1M to $10M
# of employees
251-500
Company type
For Profit
SEngine Precision Medicine

SEngine Precision Medicine

Estimated revenue
$1M to $10M
# of employees
11-50
Company type
For Profit
Symetrica

Symetrica

Estimated revenue
$1M to $10M
# of employees
11-50
Company type
For Profit
SmartScripts

SmartScripts

Estimated revenue
$1M to $10M
# of employees
51-100
Company type
For Profit
AngioChem

AngioChem

Estimated revenue
$1M to $10M
# of employees
11-50
Company type
For Profit
iotaMotion

iotaMotion

Estimated revenue
$1M to $10M
# of employees
11-50
Company type
For Profit

How to get access to the full list?

Duplicate this list

Get access to a comprehensive list of companies with their industries, location and contacts infos.

Prepare outreach

Drafting good emails makes you more likely to get get results.

Track & Follow

Keeping momentum by managing all your angel investors prospects in a pipeline with pre-set stages: "contacted", "replied", "in discussion" for ex. Follow-up tightly, close in time.

What is folk?

folk is a lightweight and easy-to-use CRM that you can leverage to build lists of contacts and manage your processes with these contacts.

How to get access to this list of companies?

You can simply duplicate the list. You will need to create a folk account in order to duplicate the list properly.

What can I do with the list after duplicating it? 

On folk, you can directly email these companies and manage them in a pipeline board.